CAS: 189060-13-7 - LAPAQUISTAT

Formule : C₃₃H₄₁ClN₂O₉

InChI : InChI=1S/C33H41ClN2O9/c1-20(37)44-19-33(2,3)18-36-25-10-9-22(34)16-24(25)30(23-7-6-8-26(42-4)31(23)43-5)45-27(32(36)41)17-28(38)35-13-11-21(12-14-35)15-29(39)40/h6-10,16,21,27,30H,11-15,17-19H2,1-5H3,(H,39,40)/t27-,30-/m1/s1

Code InChI : InChIKey=CMLUGNQVANVZHY-POURPWNDSA-N

SMILES : O=C(OCC(C)(C)CN1C(=O)C(OC(C=2C=CC=C(OC)C2OC)C3=CC(Cl)=CC=C31)CC(=O)N4CCC(CC(=O)O)CC4)C

Synonymes :

• 1-((1-(3-Acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2\r
• ,3,5-tetrahydro-4,1-benzoxazepin-3-yl)acetyl)piperidine-4-acetic acid
• 1-[2-[(3R,5S)-1-[3-(Acetyloxy)-2,2-dimethylpropyl]-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-4-piperidineacetic acid
• 2-(1-(2-((3R,5S)-1-(3-Acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3- dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydrobenzo(e)(1,4)oxazepin-3- yl)acetyl)piperidin-4-yl)acetic acid
• 4-Piperidineacetic acid, 1-(((3R,5S)-1-(3-(acetyloxy)-2,2-dimethylpropyl)-7- chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-2-oxo-4,1-benzoxazepin-3- yl)acetyl)-
• 4-Piperidineacetic acid, 1-[2-[(3R,5S)-1-[3-(acetyloxy)-2,2-dimethylpropyl]-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-
• 4-Piperidineacetic acid, 1-[[1-[3-(acetyloxy)-2,2-dimethylpropyl]-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-, (3R-trans)-
• Lapaquistat acetate
• Lapaquistat acetate [USAN]
• Tak 475
• Unii-Iuh3Ay74O3

Lapaquistat Acetate

CAS : 189060-13-7

Applications A novel squalene synthase inhibitor. Lapaquistat acetate decreased plasma cholesterol and triglyceride levels, by …

• Formule : C₃₃H₄₁ClN₂O₉
• Couleur et forme : Neat
• Masse moléculaire : 645.14

Lapaquistat acetate

CAS : 189060-13-7

LAPAQ is a hydroxyl-containing fatty acid that is synthesized by the liver and is used …

• Formule : C₃₃H₄₁ClN₂O₉
• Degré de pureté : Min. 95%
• Masse moléculaire : 645.14 g/mol

Lapaquistat acetate

CAS : 189060-13-7

Lapaquistat acetate: inhibits squalene synthase, prevents FPP to squalene conversion, treats MKD, lowers LDL cholesterol, …

• Formule : C₃₃H₄₁ClN₂O₉
• Degré de pureté : 98%
• Couleur et forme : Solid
• Masse moléculaire : 645.14